Importance Black or African American (hereinafter, Black) and Hispanic or Latino/a/x
(hereinafter, Latinx) adults are disproportionally affected by Alzheimer disease, but most …

Personalized medicine aims to tailor diagnosis and treatment based on an individual's
personal genetic make-up and other predictive biomarkers—rather than a one-size fits all …

Nearly 30 years after the 1993 National Institute of Health (NIH) Revitalization Act, which
required the inclusion of women and racial/ethnic minority groups into government-funded …

Abstract The National Alzheimer's Project Act identifies the effective treatment and
prevention of Alzheimer's by 2025 as an urgent public health mission. This priority is …

Abstract The Washington University School of Medicine Knight Alzheimer Disease Research
Center's “African American Participation in Alzheimer Disease Research: Effective …

Alzheimer's Disease and related dementias (ADRD) remain a worldwide burden to address
for persons with ADRD, their family members, and others at risk. ADRD should be …

Alzheimer disease and related dementias present considerable challenges to health-care
and medical systems worldwide. In the USA, older Black and Latino individuals are more …

Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD)
disproportionally affect Hispanic and Latino populations, yet Hispanics/Latinos are …

Introduction Disparities in dementia prevalence across racial/ethnic groups in the United
States may not be narrowing over time. Methods Data from Health and Retirement Study …

Randomized clinical trials (RCT) involve labor-intensive, highly regulated, and controlled
processes intended to transform scientific concepts into clinical outcomes. To be effective …